Conduit Pharmaceuticals Inc. 8-K Report: Key Updates on Stock & Warrants (Feb 7, 2025)

Based on the provided section of the financial report, here are the key insights and important information extracted:

1. Company Information:

• Entity Name: Conduit Pharmaceuticals Inc.
• CIK Code: 0001896212
• Address: 4851 Tamiami Trail North, Suite 200, Naples, FL 34103
• Contact: (646) 491-9132

2. Report Type:

• Filing Type: 8-K (a report of unscheduled material events or corporate changes)

3. Filing Date:

• Date of Report: February 7, 2025

4. Stock Information:

• Class of Stock: Common Stock
• Par Value: $0.0001 per share

5. Warrants Information:

• Type of Securities: Redeemable Warrants
• Exercise Terms: Each whole warrant is exercisable for one share of common stock at an exercise price of $11.50.

6. Trading Symbols:

• Common Stock Symbol: CDT (listed on NASDAQ)
• Warrants Symbol: CDTTW (listed on NASDAQ)

7. Measurement Units:

• The financial figures are reported in USD (dollars) and shares.

8. Contextual Information:

• The report provides information relevant to a specific date (February 7, 2025), indicating that the figures and disclosures pertain to the status of the company on that date.

Summary

Conduit Pharmaceuticals Inc. filed an 8-K report on February 7, 2025, detailing its common stock with a par value of $0.0001 per share and its redeemable warrants, which can be exercised for common stock at an $11.50 price. The company is publicly traded on NASDAQ under the symbols CDT for stock and CDTTW for warrants.